Novel Nanoparticle-in-Hydrogel Co-Delivery of Adjuvanted saRNA as HIV Vaccine
Award Notice Posted
- Solicitation number
- PHS-2020-1
- Agency
-
National Institute of Allergy and Infectious Diseases
National Institutes of Health, Department of Health and Human Services
- Awarded
- to Zymeron Corporation
- Set-aside
- No set-aside
Opportunity facts
- Contract number
- 75N93020C00011 Federal contract award
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- PSC
- Not on record
Notice details come from SAM.gov. Updated .
About this opportunity
ZYMERON Corporation was awarded a $300,000 contract by the Department of Health and Human Services National Institutes of Health National Institute of Allergy and Infectious Diseases to develop a novel nanoparticle-in-hydrogel co-delivery of adjuvanted saRNA as an HIV vaccine. Under the one-year contract awarded on September 25, 2020, ZYMERON Corporation will encapsulate self-amplifying RNA nanoparticles within a hydrogel matrix to potentially induce protective immune responses against HIV.
Notice text
Awarded contract 75N93020C00011 to ZYMERON CORPORATION for 300000.00 on 2020-06-01.
Notice history
5 of 7 notices listed here. See the rest on GovTribe.
On GovTribe
Work this opportunity
- Track it in your pipeline
- Find teaming partners
- Similar opportunities
- Ask GovTribe AI about this opportunity